U S Army

Treatment of Biological Warfare Agent Casualties (Fm 8-284 / Navmed P-5042 / Afman (I) 44-156 / Mcrp 4-11.1c) U S Army

Publisher Marketing: This publication serves as a guide and a reference for trained members of the Armed Forces Medical Services and other medically qualified personnel on the recognition and treatment of biological warfare (BW) agent casualties. Information contained in this publication may also be relevant for the diagnosis and treatment of patients with naturally acquired diseases or illnesses due to pathogens with BW potential. This publication 1) classifies and describes potential BW agents, 2) provides procedures for collecting, handling and labeling, shipping, and identifying potential BW agents, 3) describes procedures for medial diagnosing, treating, and management of BW casualties, and 4) describes medical management and treatment in BW operations. The material in this publication is applicable to both the conventional battlefield and the integrated environment of the battlefield. Treatment modalities contained in this manual differ from standard textbooks in that they apply to BW agent exposures. The method of exposure for most BW agents is by inhalation; whereas, the endemic disease exposure (if applicable) is by other means. Some are by ingestion, some by arthropod bites, and other by dermal contact with the agent. This does not preclude service members becoming BW casualties by these means. The use of the term "level of care" in this publication is synonymous with "echelon of care" and "role or care." The term "echelon of care" is the old North Atlantic Treaty Organization (NATO) term. The term "role of care" is the new NATO and American, British, Canadian, and Australian (ABCA) term.